Apple Health AI study recruits up to 200,000 iPhone users
The Apple Health AI study, run with OpenEvidence, will let up to 200,000 U.S. iPhone users ask medical questions in a dedicated app and rate answers grounded in clinical journals.

Apple is taking a research-first route into health chatbots. The Apple Health AI study, announced on November 15 with clinical AI company OpenEvidence, asks iPhone owners to put medical questions to a dedicated app and grade the answers, TechCrunch reported, rather than launching a consumer health assistant outright.
What happened
The company aims to enrol as many as 200,000 people in a study lasting over 12 months. Eligible users must be in the U.S., aged 21 or older, using an iPhone 15 or later on iOS 26 or newer with Apple Intelligence switched on, according to TechCrunch. Crypto Briefing said enrolment opened on the day of the announcement and the app is already available to download.
Answers come from OpenEvidence and are grounded in peer-reviewed sources including The New England Journal of Medicine, JAMA and Nature. Participants rate each response and take monthly surveys, and they can choose to share HealthKit data such as resting heart rate, activity, sleep or lab results to get more tailored replies. Crypto Briefing said the research focuses on user trust, answer quality, comprehension and effects on health decisions.
Why it matters
Privacy is central to the pitch. TechCrunch said data will be anonymised before it goes to a secure third-party cloud provider, will not be used to train AI models, and that OpenEvidence deletes queries and responses after 24 hours. The app is also meant to help people prepare for doctor visits and to point them to providers when a question raises a serious concern.
The approach contrasts with rivals. OpenAI and Anthropic already offer chatbots with health features, while Apple wants evidence on how people use clinically grounded answers before going further. "Health is deeply personal," said Sumbul Desai, Apple's health and fitness vice president, calling a dedicated study "the most thoughtful way" to understand how people engage with health AI.
The partner is a notable choice. Crypto Briefing said OpenEvidence's monthly active user base rose from 355 U.S. clinicians in January 2024 to 703,265 in June 2026, and that it reached a valuation of about $15 billion after a $250 million round in September. The Apple Health AI study also marks a shift from Apple's earlier device-centred research such as the Apple Health Study launched in February 2025.
What's next
Results will take time, given the 12-month horizon, but the study could shape whether Apple builds clinically grounded answers into its own assistant. The study's findings on trust and comprehension may also inform how regulators view consumer health chatbots. For Apple, the study adds a research track alongside the product story told in its fourth-quarter results, and AI companies are now reaching deeper into daily life, as OpenAI's ChatGPT Wallet showed. TechCrunch's report is here.
This article is for information only and is not investment advice.